Total Payments
$1,053
2024 Payments
$180.57
Companies
12
Transactions
18
Medicare Patients
971
Medicare Billing
$355,968
Payment Breakdown by Category
Food & Beverage$1,053 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,053 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $309.95 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $125.89 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $125.00 | 1 | $0 (2023) |
| Smith & Nephew, Inc. | $118.35 | 1 | $0 (2017) |
| Medtronic MiniMed, Inc. | $76.13 | 1 | $0 (2018) |
| ViiV Healthcare Company | $57.94 | 3 | $0 (2023) |
| Novo Nordisk Inc | $29.04 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $26.53 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $23.07 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.57 | 3 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $159.67 | 3 | Merck Sharp & Dohme LLC ($125.00) |
| 2022 | $124.69 | 2 | La Jolla Pharmaceutical Company ($101.42) |
| 2021 | $208.53 | 2 | La Jolla Pharmaceutical Company ($208.53) |
| 2019 | $131.53 | 2 | SANOFI-AVENTIS U.S. LLC ($109.31) |
| 2018 | $99.20 | 3 | Medtronic MiniMed, Inc. ($76.13) |
| 2017 | $148.35 | 3 | Smith & Nephew, Inc. ($118.35) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Cardio-renal | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 11/03/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: HIV | ||||||
| 03/08/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/08/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: HIV | ||||||
| 08/24/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: HIV | ||||||
| 03/10/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $101.42 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 11/09/2021 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $99.16 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 07/22/2021 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 05/07/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $109.31 | General |
| Category: DIABETES | ||||||
| 03/14/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/06/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.76 | General |
| 03/29/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.31 | General |
| 03/28/2018 | Medtronic MiniMed, Inc. | iPro2 (Device) | Food and Beverage | In-kind items and services | $76.13 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/16/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: DIABETES | ||||||
| 03/30/2017 | Smith & Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: Pharma Product | ||||||
| 03/02/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ALLERGY AND ASTHMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 162 | 609 | $82,915 | $45,126 |
| 2022 | 4 | 180 | 1,128 | $151,595 | $79,789 |
| 2021 | 5 | 232 | 986 | $131,645 | $72,920 |
| 2020 | 5 | 397 | 2,277 | $296,580 | $158,134 |
Total Patients
971
Total Services
5,000
Medicare Billing
$355,968
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 371 | $46,375 | $26,525 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 192 | $26,880 | $13,099 | 48.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 46 | $9,660 | $5,501 | 56.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 791 | $102,025 | $52,632 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 245 | $34,660 | $19,430 | 56.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 49 | $10,615 | $6,176 | 58.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 43 | $4,295 | $1,551 | 36.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 67 | 700 | $88,500 | $47,238 | 53.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 159 | $21,020 | $12,844 | 61.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 62 | 65 | $13,375 | $8,366 | 62.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 39 | $5,850 | $3,646 | 62.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 23 | $2,900 | $824.78 | 28.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 136 | 1,778 | $222,250 | $119,600 | 53.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 123 | 142 | $28,400 | $18,365 | 64.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 176 | $22,880 | $11,466 | 50.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 42 | 148 | $14,800 | $5,420 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 27 | 33 | $8,250 | $3,282 | 39.8% |
About Dr. Rizwanullah Hameed, M.D
Dr. Rizwanullah Hameed, M.D is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427008960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwanullah Hameed, M.D has received a total of $1,053 in payments from pharmaceutical and medical device companies, with $180.57 received in 2024. These payments were reported across 18 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,053).
As a Medicare-enrolled provider, Hameed has provided services to 971 Medicare beneficiaries, totaling 5,000 services with total Medicare billing of $355,968. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Brooklyn, NY
- Active Since 05/12/2006
- Last Updated 02/20/2009
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1427008960
Products in Payments
- XERAVA (Drug) $309.95
- AIRSUPRA (Drug) $125.00
- ZERBAXA (Drug) $125.00
- Santyl (Drug) $118.35
- SOLIQUA 100/33 (Drug) $109.31
- iPro2 (Device) $76.13
- DOVATO (Drug) $57.94
- Rybelsus (Drug) $29.04
- Kerendia (Drug) $26.53
- AFREZZA (Drug) $22.22
- TOUJEO (Drug) $16.58
- NIOX VERO DEVICE (Device) $13.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095